The commensal yeast Candida albicans is part of the human intestinal microflora and is considered a ''pathobiont'', a resident microbe with pathogenic potential yet harmless under normal conditions. The aim of this study was to investigate the effect of C. albicans on inflammation of the intestinal tract and the role of Bruton's tyrosine kinase (Btk). Btk is an enzyme that modulates downstream signaling of multiple receptors involved in innate and adaptive immunity, including the major anti-fungal receptor Dectin-1. Colitis was induced in wild type and Btk-/-mice by treatment with dextran sodium sulfate (DSS) and the gastrointestinal tract of selected treatment groups were then colonized with C. albicans. Colonization by C. albicans neither dampened nor exacerbated inflammation in wild type mice, but colon length and spleen weight
Introduction
The intestinal microflora plays an important not only in establishing immune tolerance but also in the development of inflammatory bowel disease (IBD) and obesity. While studies of the microbiome have mostly focused on commensal bacteria, several species of fungi are also major constituents of the mammalian gastrointestinal system, with highest fungal concentrations in the colon [1, 2] . It is estimated that fungi are detectable in all gastrointestinal segments of about 70% of healthy adults [3] , with Candida spp. being predominant [4, 5] . Candida albicans is a commensal fungus of the human gastro-intestinal tract, capable of causing life-threatening opportunistic fungal infections [6] . C. albicans is considered opportunistic pathogen or a ''pathobiont'', a resident microbe with pathogenic potential yet harmless under normal conditions. Gut-colonizing Candida can cause candidaemia [7, 8] , but mucosal damage and neutropenia are required for Candida dissemination from the colon [9] . An increase in fungal load and Candida species was observed in patients suffering from Crohn's disease [10] .
The C-type lectin Dectin-1, which recognizes cell wall b1,3-glucan, is the major receptor involved in antifungal immune responses [11] . While essential during antifungal immune responses during systemic C. albicans infections in mice, lack of Dectin-1 does not affect gastrointestinal colonization by C. albicans [12] . Dectin-1 knockout mice are more sensitive to chemically-induced colitis, presumably due to diminished immune surveillance of endogenous fungal species [1] . The contribution of fungi to the development of IBD is further illustrated by human polymorphisms in Dectin-1 associated with ulcerative colitis (UC) and its signaling molecule CARD9. The latter has been associated with both UC and Crohn's disease [1, 13, 14] . Serum antibodies against yeast cell wall components (anti-glucan, anti-laminarin and anti-chitin antibodies) are predictive for Crohn's disease and ulcerative colitis [15] .
We previously identified Bruton's tyrosine kinase (Btk) as a signaling molecule in the Dectin-1-mediated immune response to C. albicans [16] , where it contributes to macrophage phagocytosis and cytokine production. Btk-/-mice are more susceptible to systemic C. albicans infections. Btk also modulates downstream signaling of other immune receptors, including the Fcc receptor [17] and the B-cell receptor, leading to reduced B cell numbers and antibody secretion [18, 19] . For this study, we investigated the role of Btk during gastrointestinal colonization with C. albicans. Our findings add to a growing body of work that indicates probiotic effects of commensal yeasts in the gastrointestinal tract.
Materials and Methods

Candida cultures
C. albicans strain SC5314 was cultured in standard YPD medium (2% bactopeptone, 1% yeast extract, 2% glucose and 80 mg/ml uridine) for 16 hours at 30uC in a shaker.
Mouse models of Candida colonization
Animals used in this study were housed at the Whitehead Institute for Biomedical Research or at Tufts University, which are both certified by the United States Office of Laboratory Animal Welfare (OLAW) under the guidance of the Public Health Service (PHS) Policy on Humane Care and Use of Laboratory Animals. All experiments were done in compliance with regulatory guidelines defined by the Tufts University IACUC committee and Whitehead Institute IACUC committee and in accordance with procedures approved by the Massachusetts Institute of Technology Committee on Animal Care (Ploegh lab, CAC# 1011-123-14). Btk-/-animals were a kind gift from Whasif Khan [18] . For the Dectin-1 staining experiments, antibiotic-treated mice were colonized with C. albicans as described previously [20] . In short, 5-7 week-old BALB/c mice were treated with antibiotics (tetracycline, 1 mg/ml; streptomycin, 2 mg/ml; gentamicin, 0.1 mg/ml) in the drinking water and fed the purified diet AIN-93G containing glucose [21] . This diet was used because numerous yeast-form particles are found in the cecum contents of mice fed yeast extract-containing chow. Mice were inoculated with 0.1 ml C. albicans strain CKY101 and sacrificed at 4 and 18 days post-inoculation to obtain cecal contents for microscopy analysis [22] . Cecum contents was enriched for microbial cells by purification on Percoll gradients and stained with the Dectin1-CRD-Alexa 647 probe [16] . For the DSS experiments, agematched C57BL/6 mice were used as wild type control animals. To minimize differences in microbiota composition, all mice were bred and maintained in the same room at the Whitehead Animal Facility. All mice were 4 months old at the onset of experiments. Both males and females were used and genders were matched between wild type and Btk-/-groups. Chemically-induced colitis and Candida colonization experiments were performed as previously described [23, 24] . In short, colitis was experimentally induced by administration of 5% Dextran sodium sulfate (DSS) in the drinking water from day 1. On day 3, mice were inoculated with C. albicans strain SC5314 by oral gavage with 1610 7 colony forming units (CFU) in a final volume of 200 ml PBS. Mice were weighed and monitored daily and the experiment was terminated when animals had lost .20% of initial body weight. DSS was continuously administered until sacrifice. Colon and cecum were harvested for determination of colon length, cytokine levels and histology and cecum content for enumeration of fungal burdens. Spleens were harvested to determine weight and cytokine levels. To determine fungal burden, cecum contents were homogenized and plated on YPD plates with antibiotics.
Histology
For histology, tissues were fixed in 10% formalin in PBS, embedded in paraffin, sectioned and stained with Hematoxylin and Eosin (H&E) or Gomori Methenamine Silver (GMS). Immunohistochemistry was performed with antibodies directed against Myeloperoxidase (MPO) to detect neutrophils or CD68 to detect macrophages. For MPO staining, antigen retrieval was performed in Biocare's Pressure Cookers using EDTA, pH 8 solution, a polyclonal rabbit anti-human myeloperoxidase primary antibody (Dako) was diluted to 1:3500 and a Dako's Rabbit Envision detection kit was used. For CD68 staining antigen retrieval was performed with Borg Decloaker RTU solution (Biocare Medical) in a pressurized Decloaking Chamber (Biocare Medical) for 3 min. As a primary antibody rat monoclonal anti-CD68 [FA-11] antibody (Abcam) was diluted to 1:500 followed by biotin-conjugated secondary donkey anti-rat antibodies (Jackson ImmunoResearch). The Vectastain Elite ABC immunoperoxidase detection kit (Vector Labs PK-6101) followed by Dako Liquid DAB1 Substrate (Dako) was used for visualization. For quantification of neutrophil and macrophage numbers, 56100 grids were counted at a 40x magnification for 3 individual animals.
Cytokine measurements
Colons and spleen were homogenized in 1 ml PBS followed by cytokine analysis using a Th1/Th2/Th17 mouse cytometric bead array (BD Biosciences) and LSR Flow Cytometer (Whitehead Institute Flow Cytometry Core) according to the manufacturer's directions. Separate ELISA assays were performed for IL-1b (BD Biosciences) and TGF-b (Abcam) according to the manufacturer's instructions.
Statistical analysis
For regular statistical analysis between samples within groups a one-way ANOVA test was performed with Holm-Sidak correction for multiple comparisons using Prism 6 software. We applied this test to 7 comparisons for all our experiments (colon length, spleen weight and cytokine data). 7 comparisons were: 1) wild type control vs wild type DSS. 2) wild type control vs wild type DSS/ Candida. 3) wild type DSS vs wild type DSS/Candida. 4) Btk-/-control vs Btk-/-DSS. 5) Btk-/-control vs Btk-/-DSS/Candida. 6) Btk-/-DSS vs Btk-/-DSS/Candida. 7) wild type DSS/Candida vs Btk-/-DSS/Candida. A student t test was used for a comparison between two values using Prism 6 software. For the clustering analysis, uncentered correlation with average linkage was performed using the program Cluster 3.0 [25] . Clustered matrices were visualized with Java TreeView [26] . Linear regression analysis was performed using R software (http://www.r-project.org/) to identify potential correlations between cytokine levels and colon lengths or spleen weights.
Results
C. albicans adapts to the gastrointestinal tract by formation of hyphae and exposure of b1,3-glucan
We first studied the adaptation of C. albicans to the gastrointestinal tract and the exposure of the Dectin-1 ligand b1,3-glucan in the yeast cell wall. To allow for colonization of the gastrointestinal tract in the absence of inflammation, we chose the previously described mouse model of C. albicans inoculation by oral gavage after antibiotics treatment [20] . Four or 18 days post-inoculation, C. albicans was retrieved from the caecum and stained with a fluorescent soluble carbohydrate recognition domain of Dectin-1 (Dectin1-CRD-Alexa647) [16] . At the 4-day time point, yeast morphology presented as short hyphae emanating from the yeast particles. The yeast-form mother cell stained extensively with Dectin1-CRD-Alexa647, while the germ tube showed less staining ( Figure 1A ). At the 18-day time point, we observed long hyphae that showed extensive staining with the soluble receptor domain ( Figure 1B ). We conclude that after an initial phase of adaptation to the gastrointestinal tract, C. albicans filaments contain b1,3-glucan that is accessible to Dectin-1.
Gastrointestinal colonization by C. albicans has protective effects in Btk-/-animals Next we investigated the impact of C. albicans colonization on inflammation of the gastrointestinal tract. We chose the dextran sodium sulfate (DSS) colitis mouse model in conjunction with C. albicans colonization by oral gavage [23, 24] . Colitis was induced in wild type and Btk-/-animals by provision of DSS in the drinking water, followed by an oral inoculum of 1610 7 colony forming units of C. albicans on day 3 ( Figure 2A ). The experiment included control, DSS only and DSS/Candida treatment groups of wild type and Btk-/-animals. Animals were sacrificed 8 days after initiation of the experiment. DSS-treated and DSS/Candida-treated wild type and Btk-/-animals lost weight at a similar rate ( Figure 2B ). For both wild type and Btk-/-animals, Candida hyphae were visible when colons were stained with fungi-specific Gomori Methenamine Silver (GMS) ( Figure 2C ). The hyphal morphology observed in these histology slides corroborates our results that C. albicans adapts to the gastrointestinal tract by hyphae formation ( Figure 1 ). We next quantified C. albicans colonization of the wild type and Btk-/-DSS/Candida groups. The numbers of Candida colony-forming units (CFUs) from caecum samples were slightly higher in the DSS/Candida-treated Btk-/-animals compared to wild type ( Figure 2D ). Addition of DSS to the drinking water resulted in statistically significant shortening of the colon of wild type animals ( Figure 2E ). Wild type animals that received the DSS/Candida combination treatment also showed significantly reduced colon lengths compared to the wild type control group. There was no difference in colon length between the wild type DSS and DSS/ Candida-treated groups, suggesting that C. albicans neither increased nor decreased inflammation. Colon shortening as a result of DSS-only treatment was also observed for the Btk-/-mice. However, the DSS/Candida-treated Btk-/-animals displayed significantly longer colons compared to DSS-treated Btk-/-mice (p,0.05) and compared to DSS/Candida-treated wild type animals (p,0.005) ( Figure 2E ). These results suggest that in the Btk-/-animals, colonization by C. albicans may dampen inflammation. As a proxy for systemic inflammation we measured spleen weight, as increased leukocyte numbers enlarge the spleen. Wild type animals showed a significant increase in spleen weight upon treatment with the DSS/Candida combination ( Figure 2F) . Btk-/-animals treated with DSS had significantly enlarged spleens and spleen weight was reduced in the DSS/Candida-treated group, although this difference did not reach statistical significance. DSS/Candida-treated Btk-/-animals showed reduced spleen weight compared to the wild type DSS/Candida-treated animals (p,0.05). Candida colonization thus affords a measure of protection against DSS-induced colitis in Btk-/-animals.
Colons of Btk-/-animals have reduced macrophage infiltrates
To further assess the severity of inflammation, we performed H&E staining of the distal colon of the wild type and Btk-/-control and treatment groups. Microscopy showed that all treatment groups suffered from severe cryptitis, crypt abscesses and (multi)focal ulcerations ( Figure 3A) . For a quantitative analysis, the H&E-stained colons were blindly graded for the presence of normal mucosa (1), cryptitis (2), crypt abscesses (3), focal ulcerations (4) and multifocal ulcerations (5) . The colons of some Btk-/-animals of the DSS/Candida treatment groups showed improved histology, but the difference between groups did not reach statistical significance. To examine the composition of the colon inflammatory infiltrates we performed immunohistochemical analysis. Neutrophil invasion as measured by MPO staining was observed upon treatment with DSS and DSS/ Candida in both wild type and Btk-/-colons and the number of neutrophilic infiltrates was comparable between groups (Figure 3B) . A CD68 stain showed macrophage infiltrates in the wild type DSS and DSS/Candida condition, but a severely reduced number of macrophages in the colons of Btk-/-animals ( Figure 3C ).
Btk-/-animals show elevated pro-inflammatory cytokines and decreased TGF-b levels
We next investigated if colonization by C. albicans and the reduced macrophage numbers in the Btk-/-colons impact local cytokine levels in the colon and systemic cytokine levels in the spleen. Cytokine measurements were performed on lysates of the proximal colon ( Figure 4A ) and spleen ( Figure 4B ). Statistical differences between 7 selected groups were determined by oneway ANOVA test with Holm-Sidak's correction for multiple comparisons. In the colon of wild type animals, IL-10 levels were significantly lowered as a result of DSS or DSS/Candida treatment (p,0.05 and p,0.005, respectively) ( Figure 4A) . Colonic IL-6 was elevated in all wild type and Btk-/-treatment groups, but only the difference between Btk-/-control and DSS treatment was significant (p,0.05) ( Figure 4A ). In the spleens of Btk-/-mice, IL-17A levels were significantly decreased in both treatment conditions (p,0.05) ( Figure 4B ). This decrease is due mainly to the high levels of IL-17A in Btk-/-control spleens, suggesting elevated levels of this cytokine in the absence of any treatment or inflammation. Furthermore, IFN-c levels in the spleen were significantly higher in DSS-treated wild type mice compared to the control group. Surprisingly, wild type spleen IL1b levels were lowered in response to DSS/Candida treatment, while Btk-/-animals showed a reverse trend. Of all cytokines analyzed, spleen TGF-b levels showed the most striking differences between treatment groups. TGF-b levels were similar in wild type and Btk-/-control groups and DSS/Candida treatment reduced TGF-b levels for both genotypes (p,0.01 and p,0.001, respectively). In Btk-/-animals, C. albicans colonization in combination with DSS treatment led to a significant decrease in TGF-b levels compared to DSS treatment alone (p,0.01). To investigate functional relationships between the investigated cytokines we performed clustering analysis of all cytokine measurements. The values of the wild type and Btk-/-control groups were averaged at 0 and other measurements were expressed as relative log values ( Figure 4C) . The first functional cluster of pro-inflammatory cytokines that emerged consisted of colon IL-1b, colon IL-17A, colon TNF, spleen IL-1b, colon IFN-c, spleen IL-10 and spleen TNF. For this group of cytokines, a general upregulation was observed in the DSS and DSS/Candida conditions, which was more pronounced in the Btk-/-groups. A second cluster of proinflammatory cytokines consisted of colon IL-6, spleen IFN-c and spleen IL-6 and was equally elevated in DSS and DSS/Candida groups of both wild type and Btk-/-animals. A third cluster of anti-inflammatory cytokines consisting of colon TGF-b, colon IL-10, spleen TGF-b and spleen IL-17A was downregulated in the DSS and DSS/Candida groups of both wild type and Btk-/-animals. In summary, Btk-/-treatment groups display a general increase in pro-inflammatory cytokine levels in colon and spleen and reduced levels of splenic TGF-b compared to wild type animals.
TGF-b, IL-10 and IL-17A are associated with inflammation
Because of the reduced inflammation seen in the Btk-/-animals, we were curious which of the cytokine profile best correlated with colon length or spleen weight in wild type and Btk-/-animals. We performed linear regression analysis and determined p and R 2 values of the correlation coefficients. For the wild type animals, TGF-b levels correlated with colon length and negatively correlated with spleen weight ( Figure 4D ). Colon IL-10 levels and colon length were also significantly correlated. In other words, lowering of the anti-inflammatory cytokines TGF-b and IL-10 best predicts inflammation in wild type animals. For the Btk knockout animals, spleen IL-17A correlated with colon length and negatively correlated with spleen weight, while colon IL-17A was negatively correlated with colon length ( Figure 4E) . We conclude that in Btk-/-animals, reduced inflammation is associated with high spleen IL-17A levels and decreased IL-17A in the colon.
Discussion
C. albicans is a commensal yeast that is part of the normal human microflora, although most studies have focused on the pathogenic properties of this opportunistic fungus. Here we show that colonization of the gastrointestinal tract by C. albicans alters inflammatory responses in a mouse model of colitis and improves some colitis parameters. Whereas wild type animals do not noticeably benefit (or suffer) from the presence of C. albicans, Btk-/-animals show a measure of protection as assessed by colon length and spleen weight (Figure 2) . Macrophage, but not neutrophil, infiltration of the colon in response to DSS or DSS/ Candida treatment is severely reduced in Btk-/-animals ( Figure 3) . We hypothesize that this reduction in combination with the lowered phagocytic capacity and reduced ROS production of Btk-/-macrophages causes the altered inflammatory responses of the Btk-/-animals during C. albicans colonization. In the colons and spleen of Btk-/-animals we find elevated levels of pro-inflammatory cytokines and reduced levels of anti-inflammatory cytokines during DSS or DSS/Candida treatment. For wild type animals, a reduction in colon IL-10 and spleen TGF-b is associated with increased inflammation. For Btk-/-animals, reduced inflammation is associated with elevated spleen IL-17A levels and reduced colon IL-17A levels ( Figure 4) .
We demonstrate that Candida adapts to the gastrointestinal tract by the formation of hyphae and exposure of the Dectin-1 ligand b1,3-glucan ( Figure 1A and B) . C. albicans, while in the gut, can therefore have potent immuno-stimulatory effects. Previous studies showed staining of fungal cells using a Dectin-1 CRD domain, but the identity and source of the stained cells was unknown [1] . In our experiments, mice were fed on feed devoid of yeast extract, thereby excluding an extraneous source of yeast-like particles. The combination of staining with the fluorescent Dectin-1 CRD domain allowed us to identify gut-adapted C. albicans in murine cecal contents. At 4 days post-inoculation, germ tubes produced by C. albicans cells colonizing the gastrointestinal tract stained poorly with Dectin-1, consistent with previous observations of differential exposure of b1,3-glucan in yeasts and hyphal elements grown in laboratory culture [27] . Later in the time course of colonization (day 18 post-inoculation), gene expression in colonizing cells changes [28] and we found numerous hyphal filaments that stained with Dectin-1. The observation of high b1,3-glucan exposure late during colonization replicates earlier findings of b1,3-glucan unmasking late during systemic infection [29] . Physiological changes that affect Dectin-1 binding occur as C. albicans adapts to growth in the gastrointestinal tract.
Conflicting data have been published on the importance of Dectin-1 during Candida colonization or the development of colitis. Dectin-1 knockout mice were found to be equally sensitive [30] or more susceptible to DSS-induced colitis [1] . The latter report points at the role of endogenous fungi of the gastrointestinal tract, therefore a different composition of the microbiome may explain the opposing results. However, in our hands the colon length of the DSS/Candida-treated Dectin1-/-animals was not significantly different from DSS/Candida-treated wild type animals (data not shown). In DSS-independent experiments, colonization of the gastrointestinal tract by C. albicans was not affected by the presence or absence of Dectin-1 [12] . Together, these results suggest that Dectin-1 plays a role in anti-fungal immunity only in conjunction with a diseased state of the colon. Besides Dectin-1, pattern recognition receptors like DC-SIGN, Mannose receptor and Mincle are known to be involved in cellular immune responses against C. albicans. Their roles during C. albicans colonization of the gastrointestinal tract remain to be investigated.
Which of the changes that result from the absence of Btk could explain the observed protective effect of the DSS/Candida treatment? Btk is an important component of B-cell receptor signaling and Btk-/-animals have reduced B cell numbers and impaired antibody secretion [18, 19] . B cells are prominent immune cells in the small intestine's lamina propria where their ability to secrete IgA is crucial for normal intestinal gene expression [31] . Despite this, DSS induces colitis in B celldeficient mice [32] without affecting composition of the gastrointestinal microbiome [31] . In addition to B cell defects, Btk deletion also leads to innate immune deficiencies. Btk-/-mice have reduced numbers of polymorphonuclear leukocyte (PMN) numbers and Btk-/-neutrophils are deficient in ROS and NO production [33] [34] [35] . Mangla et al. also reported reduced inflammatory responses of Btk-/-knockout mice in different infection models [33] . Our immunohistochemistry experiments show reduced numbers of macrophages in DSS-and DSS/Candida-treated Btk-/-colons while neutrophil numbers are comparable to wild type ( Figure 3) . Because infiltrating macrophages and neutrophils cause severe immunopathology during colitis, we hypothesize that their lower numbers and reduced reactivity contribute to the reduced inflammation in the Btk-/-DSS/Candida treatment group. We previously showed that Btk interacts with Dectin-1 and that Btk-/-macrophages have phagocytic defects [16] , possibly leading to an increase in fungal load in Btk-/-animals ( Figure 2D ). In conjunction with the lower numbers of macrophage infiltrates in Btk-/-colons, these observations might explain the altered inflammatory response of Btk-/-animals in response to DSS treatment and C. albicans colonization.
Cytokine analysis of spleen samples showed a general proinflammatory response with upregulation of IL1-b, IL-17A (colon), TNF, IFN-c, IL-10 (spleen) and IL-6) and down regulation of TGF-b, IL-10 (colon), IL17A (spleen) ( Figure 3A, B, C) . There was no clear-cut effect of Candida colonization on the cytokines measured. Clustering analysis showed that wild type and Btk-/-animals treated with DSS or DSS/Candida similarly induce expression of IFN-c and IL-6, cytokines often associated with trauma induced by C. albicans infection/colonization (Figure 3C) . However, Btk-/-animals treated with DSS or DSS/ Candida showed a higher upregulation of IL1-b, IL-17A, TNF, IFN-c and IL-10 compared to wild type treatment groups. Therefore we conclude that reduced inflammatory responses in Btk-/-animals during Candida colonization are associated with relatively high levels of pro-inflammatory cytokines. These observations support the hypothesis that reduced inflammatory responses in Btk-/-animals are due to less responsive innate immune cells.
Correlation analysis showed that inflammation in wild type mice is associated with decreased TGF-b and IL-10 levels ( Figure 4D ). TGF-b is an important anti-inflammatory cytokine that is involved in the induction of regulatory T cells and Th17 cells. Interestingly, it has been previously reported that TGF-b transgenic mice develop age-related autoimmune disease, characterized by T-cell activation and colitis [36] [37] [38] . The antiinflammatory IL-10 is produced by monocytes and epithelial cells and plays an important role in immune regulation in relation to microbiota in the gastrointestinal tract [39] . Both TGF-b and IL-10 are important cytokines in maintenance of gut health, which fits with the negative correlation with DSS-induced inflammation in wild type animals. The cytokine that is most closely correlated with the inflammatory response of Btk-/-animals is IL-17A. Increased spleen IL-17A levels are associated with increased colon length and decreased spleen weight. On the contrary, low colon IL-17A levels are associated with increased colon length ( Figure 4E) . In other words, ''healthy'' Btk-/-animals have high spleen IL-17A levels and low colon IL-17A levels. When comparing IL-17A levels in control groups and DSS and DSS/Candida groups, Btk-/-animals show an opposite trend compared to wild type animals. In Btk-/-animals, colon IL-17A is upregulated during inflammation and in the spleen lower levels of IL-17A are observed ( Figure 4A,  B) . IL-17A is a key cytokine in the Th17 anti-fungal immune response that can be produced by Th17 cells [40, 41] , but also to a minor extend by neutrophils [42] and innate lymphoid cells [43] . Th17 cytokines including IL-17A are generally linked to severity of colitis but also induce protective regulatory mechanisms in epithelial cells [44] .
Considering it's central role in the development of colitis, altered regulation and secretion of IL-17A might contribute to the reduced inflammatory response in Btk-/-animals.
Favorable effects of C. albicans colonization of the gut were previously reported. b-glucan, a major C. albicans cell wall component and the ligand Dectin-1, was shown to have potent anti-inflammatory effects in a mouse colitis model [45] . In addition, in the recovery phase after antibiotics treatment, the presence of C. albicans promoted bacterial diversity in the mouse caecum, specifically enriching Bacteroidetes populations and reducing Lactobacillus species [46, 47] . This link between C. albicans and Bacteroidetes is interesting, because Bacteroides fragilis was shown to induce Tregs and mucosal tolerance [48] . The pleiotropic effect of Btk deletion makes it difficult to pinpoint the mechanism of protection in the DSS/Candida-treated Btk-/-animals. Conditional knockout animals with Btk deletion in specific cell types might assist in future experiments. In addition, the available Btk inhibitors in combination with Candida colonization might replicate the protective phenotype and thus Btk could be a possible target for the treatment of inflammatory conditions such as ulcerative colitis and Crohn's disease.
